medac Pharma appoints Tony Johnson as Managing Director
Stirling, 5th May 2021
.png)
medac Pharma is delighted to announce the appointment of Tony Johnson as Managing Director. The new Managing Director began his new position in the company, which specialises in the therapy areas of oncology, urology, haematology and autoimmune on the 4th of May. Tony will be responsible for all aspects of medac Pharma’s commercial, regulatory, finance and marketing departments in the UK.
Tony graduated with a degree in Pharmacology from Manchester University and began his career in the pharmaceutical industry working for Parke Davis in Pharmacology. From there he went on to become a Medical Rep and then Product Manager with the company. In 1995 Tony diversified into product management and marketing roles with Faulding Pharmaceuticals, including Group Product Manager and Sales and Marketing Director.
Since joining medac as Marketing Director in 2002, Tony has been a member of the management team and his years of experience both with medac Pharma and previous companies here have led him to be the natural successor for the role of Managing Director. “I am proud to be given the opportunity to take over the business at such an exciting time" Tony says on his first day in the new role.
Tony‘s announcement comes as former MD Alastair McMurray announces his retirement after 24 years in charge of medac Pharma.
About medac Pharma
medac Pharma is a privately owned, pharmaceutical company specialising in product development and the treatment of diseases within the key areas of oncology, autoimmune and urology.
medac GmbH was originally founded in Germany in 1970 and the UK operation was established in 1993. Since then we have become known for developing innovative products, especially in less common indications, which have resulted in a comprehensive portfolio of pharmaceutical products which help make a positive difference to the lives of your patients. We are committed to supplying therapeutic products and providing the diagnostic resources to identify diseases. We continue to invest in our manufacturing and logistic capabilities to ensure we meet the increasing demand of both healthcare professionals and patients’ needs.
Press contact:
Lauren Addison - Marketing Communications Manager
[email protected]
Phone: 07557 023607